Ma et al. developed a hafnium-based cationic metal–organic layer (CMOL) for the delivery of siRNA cocktails targeting survivin, HIF-1α, and TGF-β to enhance the effect of cancer radiotherapy and to overcome the radioresistance of tumor cells. The gene discussed is BIRC5; the disease is cancer.